• Chairman of PharmaResearch
    Jung Sang-soo

    Departed Daewoong Pharmaceutical, Founded PharmaResearch, Achieved KRW 200 Billion Sales, and Expanded Overseas with Medical Device Rejuran

    Last Updated on Dec 31, 2024

    copy_url  Copy Url : https://www.koreawho.com/profile/JungSangsoo

Life Summary
Jung Sang-soo is the Chairman of the Board of Directors at PharmaResearch.

He is actively expanding the European market entry of the medical device Rejuran and pursuing a domestic botulinum toxin business.

He was born on April 25, 1958, in Gangneung, Gangwon Province.

He graduated from Gangneung High School and the College of Pharmacy at Chung-Ang University.

At Daewoong Pharmaceutical, he served as the head of the development team and handled global pharmaceutical licensing.

In 1993, he founded PharmaResearch Products (currently PharmaResearch) and began a consulting business for product licensing and development.

The company grew rapidly with the launch of the wrinkle improvement medical device Rejuran.

After acquiring the filler business division of Estra, a subsidiary of Amorepacific Group, he established PharmaResearch Bio.

In 2020, he stepped down as CEO, transitioning PharmaResearch to a professional management system, and assumed the role of Chairman of the Board.

#JungSangSoo #PharmaResearch #Rejuran #BotulinumToxin #KoreanPharmaceuticals #Gangneung #MedicalDevice #ChungAngUniversity #Estra #ProfessionalManagement